2001
DOI: 10.2169/internalmedicine.40.175
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Acute and Fulminant Hepatitis in Japan.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 25 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…ALF in Japan has been typically regarded as fulminant hepatitis, for which the diagnostic criteria were established by the Inuyama Symposium held in 1981 [2]. Among patients with ALF, those showing histological findings of hepatitis (characterized by inflammatory lymphocyte infiltration), as well as 40% or less of the standardized prothrombin timeand grade II or more severe hepatic encephalopathy, are diagnosed as having “fulminant hepatitis”, which is classified as acute and subacute types in the same manner as ALF [2, 3]. Thus, fulminant hepatitis is almost synonymous with ALF in the United States and Europe as well as in Japan, except that patients without histological evidence of hepatitis are excluded from both disease conditions in Japan.…”
Section: Introductionmentioning
confidence: 99%
“…ALF in Japan has been typically regarded as fulminant hepatitis, for which the diagnostic criteria were established by the Inuyama Symposium held in 1981 [2]. Among patients with ALF, those showing histological findings of hepatitis (characterized by inflammatory lymphocyte infiltration), as well as 40% or less of the standardized prothrombin timeand grade II or more severe hepatic encephalopathy, are diagnosed as having “fulminant hepatitis”, which is classified as acute and subacute types in the same manner as ALF [2, 3]. Thus, fulminant hepatitis is almost synonymous with ALF in the United States and Europe as well as in Japan, except that patients without histological evidence of hepatitis are excluded from both disease conditions in Japan.…”
Section: Introductionmentioning
confidence: 99%